Annual bowel cancer screening figures released by NHS England reveal that the programme is identifying approximately 100 cancers per week — a finding the health service is highlighting to encourage greater participation, particularly among people in their 50s.
Participation Gap in Younger Age Groups
The data, which covers the twelve months from April 2024 to March 2025, shows that people in their 50s are less likely than other age groups to return their home screening kits. Among 54-year-olds specifically, just 56.2% took part in the programme during that period, according to NHS England.
That figure — slightly above half of all eligible individuals in that age bracket — points to a substantial portion of the population not completing a test that the screening programme relies on for early detection.
How the Screening Process Works
The NHS bowel cancer screening programme sends eligible individuals a home testing kit, known as a faecal immunochemical test (FIT). The kit requires a small stool sample to be collected and returned by post for laboratory analysis. A positive result prompts a follow-up colonoscopy, which can identify cancers or pre-cancerous polyps at a stage when treatment is more likely to be effective.
Because the test is completed at home and returned by post, participation depends largely on individuals choosing to act after receiving the kit — a step that, the NHS figures suggest, a significant minority in their 50s are not taking.
Scale of Detection
The weekly detection rate of around 100 cancers underlines the volume of cases being identified through the programme across England. NHS England is using this figure as part of its appeal for higher kit return rates, framing the screening programme as an active and productive route to diagnosis rather than a precautionary measure with uncertain yield.
The 2024–25 statistics represent the most recent annual snapshot of how the programme is performing and where participation gaps remain most pronounced. NHS England's focus on the 50s age cohort in its public messaging reflects the data showing this group trails other eligible age bands in uptake.
Why Uptake Matters
Bowel cancer, when detected at an early stage, is associated with considerably better outcomes than when it is found after symptoms have already developed. Screening programmes are designed to identify disease before it becomes symptomatic, which is why participation rates are treated as a meaningful indicator of a programme's reach and effectiveness.
A participation rate of 56.2% among 54-year-olds means that close to four in ten people in that group did not return a kit during the year in question. NHS England's release of these figures appears aimed at narrowing that gap by drawing attention to the tangible number of cancers the programme is already finding each week — and, implicitly, to the cases that might be missed when kits go unreturned.
The full annual bowel cancer screening statistics for 2024–25 are available via NHS England's website.